ghrelin and glp-1 Functional interaction between regulates feeding through the vagal afferent system GLP-1 | Summary

Discuss side effects or concerns with your healthcare provider

An open-label RCT in n = 44 patients with obesity and subclinical binge-eating found a greater reduction in binge-eating at 12 weeks in liraglutide versus control (diet and exercise) groups [20]

It focuses exclusively on medical weight loss rather than a broad menu of services, which keeps the experience streamlined

No side effects were reported, and some patients felt better within just 2 weeks

Illinois Medicaid covers GLP-1s for diabetes

Clinical studies have demonstrated that retatrutide induces substantial and sustained weight loss, outperforming placebo and certain existing obesity drugs